FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer
Bevacizumab Progression-free Survival Benefit Upheld in AVEREL Trial - The ASCO Post
Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysis
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma | NEJM
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial - Annals of Oncology
Updated Results From IMbrave150 Underscore the Benefit of Frontline Atezolizumab Plus Bevacizumab in Unresectable HCC
Improved Survival with Bevacizumab in Advanced Cervical Cancer | NEJM
PLOS ONE: Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis
Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study
TURANDOT: First-Line Bevacizumab Plus Capecitabine Shows Non-Inferior Overall Survival versus Bevacizumab plus Paclitaxel for Metastatic Breast Cancer | ESMO
Avastin® (bevacizumab) Clinical Trials | MRCC Treatment
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial - The Lancet Respiratory
Overall survival according to the addition of bevacizumab to first-line... | Download Scientific Diagram
IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC - Journal of Thoracic Oncology
Overall survival for patients randomized to receive (A) bevacizumab (n... | Download Scientific Diagram
Avastin® (bevacizumab) Clinical Trials | MCRC Treatment
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma | NEJM
Avastin (Bevacizumab): Uses, Dosage, Side Effects, Interactions, Warning
Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer - Gynecologic Oncology
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer
Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study | Anticancer Research
